| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |